Personal information

No personal information available

Activities

Collapse all

Education and qualifications (3)

University of Edinburgh: Edinburgh, GB

MBChB
Qualification
Source: Self-asserted source
Nikolas Plevris

University of Edinburgh: Edinburgh, GB

MD (Gastroenterology)
Qualification
Source: Self-asserted source
Nikolas Plevris

RCPE: Edinburgh, GB

MRCP
Qualification
Source: Self-asserted source
Nikolas Plevris

Works (24)

Real-world Cohort Study on the Effectiveness and Safety of Filgotinib Use in Ulcerative Colitis

Journal of Crohn's and Colitis
2025-01-11 | Journal article
DOI: 10.1093/ecco-jcc/jjad187
Contributors: Beatriz Gros; Mairi Goodall; Nik Plevris; Nathan Constantine-Cooke; Alexander T Elford; Claire O’Hare; Colin Noble; Gareth-Rhys Jones; Ian D Arnott; Charlie W Lees
Source: check_circle
Crossref

Tofacitinib versus Vedolizumab Among Bio-naïve Patients with Ulcerative Colitis: A Real-World Propensity-Weighted Comparison

Journal of Crohn's and Colitis
2024-12-11 | Journal article
DOI: 10.1093/ecco-jcc/jjae188
Contributors: Beatriz Gros; Nathan Constantine-Cooke; Jake Kennedy; Alexander T Elford; Claire O’Hare; Colin Noble; Gareth-Rhys Jones; Ian D Arnott; Charlie W Lees; Nikolas Plevris
Source: check_circle
Crossref

Large-scale clustering of longitudinal faecal calprotectin and C-reactive protein profiles in inflammatory bowel disease

2024-11-11 | Preprint
DOI: 10.1101/2024.11.08.24316916
Contributors: Nathan Constantine-Cooke; Marie Vibeke Vestergaard; Nikolas Plevris; Karla Monterrubio-Gomez; Clara Ramos Belinchon; Solomon Ong; Alexander T. Elford; Beatriz Gros; Aleksejs Sazonovs; Gareth-Rhys Jones et al.
Source: check_circle
Crossref

Real-world effectiveness of upadacitinib in Crohn’s disease: a UK multicentre retrospective cohort study

Frontline Gastroenterology
2024-07 | Journal article
DOI: 10.1136/flgastro-2024-102668
Contributors: Alexander Thomas Elford; Maria Bishara; Nikolas Plevris; Beatriz Gros; Nathan Constantine-Cooke; James Goodhand; Nicholas A Kennedy; Tariq Ahmad; Charlie W Lees
Source: check_circle
Crossref

Validation of the ACE [Albumin, CRP, and Endoscopy] Index in Acute Colitis: Analysis of the CONSTRUCT dataset

Journal of Crohn's and Colitis
2024-02-26 | Journal article
DOI: 10.1093/ecco-jcc/jjad148
Contributors: Rebecca K Grant; Gareth-Rhys Jones; Nikolas Plevris; Ruairi W Lynch; William M Brindle; Hayley A Hutchings; John G Williams; Laith Alrubaiy; Alan Watkins; Charlie W Lees et al.
Source: check_circle
Crossref

Multiple infliximab biosimilar switches appear to be safe and effective in a real‐world inflammatory bowel disease cohort

United European Gastroenterology Journal
2023-03 | Journal article
DOI: 10.1002/ueg2.12357
Contributors: Beatriz Gros; Nikolas Plevris; Nathan Constantine‐Cooke; Mathew Lyons; Claire O'Hare; Colin Noble; Ian D. Arnott; Gareth‐Rhys Jones; Charlie W. Lees; Lauranne A. A. P. Derikx
Source: check_circle
Crossref

Longitudinal Faecal Calprotectin Profiles Characterise Disease Course Heterogeneity in Crohn’s Disease

2022-08-16 | Preprint
DOI: 10.1101/2022.08.16.22278320
Contributors: Nathan Constantine-Cooke; Karla Monterrubio-Gómez; Nikolas Plevris; Lauranne A.A.P Derikx; Beatriz Gros; Gareth-Rhys Jones; Riccardo E. Marioni; Charlie W. Lees; Catalina A. Vallejos
Source: check_circle
Crossref

Patterns of emergency admission for IBD patients over the last 10 years in Lothian, Scotland: a retrospective prevalent cohort analysis

Alimentary Pharmacology & Therapeutics
2022-07 | Journal article
DOI: 10.1111/apt.16867
Contributors: Mathew Lyons; Lauranne A. A. P. Derikx; James Fulforth; Sophie McCall; Nikolas Plevris; Philip W. Jenkinson; Kathryn Kirkwood; Spyros Siakavellas; Laura Lucaciu; Nathan Constantine‐Cooke et al.
Source: check_circle
Crossref

Disease Monitoring in Inflammatory Bowel Disease: Evolving Principles and Possibilities

Gastroenterology
2022-04 | Journal article
DOI: 10.1053/j.gastro.2022.01.024
Contributors: Nikolas Plevris; Charlie W. Lees
Source: check_circle
Crossref

Effectiveness and Safety of Adalimumab Biosimilar SB5 in Inflammatory Bowel Disease: Outcomes in Originator to SB5 Switch, Double Biosimilar Switch and Bio-Naïve SB5 Observational Cohorts

Journal of Crohn's and Colitis
2021-12-18 | Journal article
DOI: 10.1093/ecco-jcc/jjab100
Contributors: Lauranne A A P Derikx; Heather W Dolby; Nikolas Plevris; Laura Lucaciu; Caitlin S Rees; Mathew Lyons; Spyros I Siakavellas; Nathan Constantine-Cooke; Philip Jenkinson; Shanna Su et al.
Source: check_circle
Crossref

Normalization of Fecal Calprotectin Within 12 Months of Diagnosis Is Associated With Reduced Risk of Disease Progression in Patients With Crohn’s Disease

Clinical Gastroenterology and Hepatology
2021-09 | Journal article
DOI: 10.1016/j.cgh.2020.08.022
Contributors: Nikolas Plevris; James Fulforth; Mathew Lyons; Spyros I. Siakavellas; Philip W. Jenkinson; Cher S. Chuah; Laura Lucaciu; Rebecca J. Pattenden; Ian D. Arnott; Gareth-Rhys Jones et al.
Source: check_circle
Crossref

Real‐world effectiveness and safety of ustekinumab for the treatment of Crohn's disease: the Scottish ustekinumab cohort

Journal of Gastroenterology and Hepatology
2021-08 | Journal article
DOI: 10.1111/jgh.15390
Contributors: Nikolas Plevris; James Fulforth; Spyros Siakavellas; Andrew Robertson; Rebecca Hall; Amy Tyler; Philip W Jenkinson; Iona Campbell; Cher Shiong Chuah; Claire Kane et al.
Source: check_circle
Crossref

Real-world experience with tofacitinib in ulcerative colitis - a systematic review and meta-analysis

2021-04-30 | Other
DOI: 10.1101/2021.04.27.21256170
Contributors: L Lucaciu; N Constantine-Cooke; N Plevris; S Siakavellas; LAAP Derikx; GR Jones; CW Lees
Source: check_circle
Crossref

Vedolizumab is effective and safe in elderly inflammatory bowel disease patients: a binational, multicenter, retrospective cohort study

United European Gastroenterology Journal
2020-11 | Journal article
DOI: 10.1177/2050640620951400
Contributors: Nathaniel Aviv Cohen; Nikolas Plevris; Uri Kopylov; Anna Grinman; Bella Ungar; Henit Yanai; Haim Leibovitzh; Naomi Fliss Isakov; Ayal Hirsch; Einat Ritter et al.
Source: check_circle
Crossref

Temporal Trends in Surgical Resection Rates and Biologic Prescribing in Crohn’s Disease: A Population-based Cohort Study

Journal of Crohn's and Colitis
2020-09-16 | Journal article
DOI: 10.1093/ecco-jcc/jjaa044
Contributors: P W Jenkinson; N Plevris; S Siakavellas; M Lyons; I D Arnott; D Wilson; A J M Watson; G-R Jones; C W Lees
Source: check_circle
Crossref

Effectiveness of ustekinumab dose escalation in Crohn’s disease patients with insufficient response to standard‐dose subcutaneous maintenance therapy

Alimentary Pharmacology & Therapeutics
2020-07 | Journal article
DOI: 10.1111/apt.15784
Contributors: Uri Kopylov; Jurij Hanzel; Claire Liefferinckx; Davide De Marco; Nicola Imperatore; Nikolas Plevris; Iria Baston‐Rey; Richard J. Harris; Marie Truyens; Viktor Domislovic et al.
Source: check_circle
Crossref

Association of trough vedolizumab levels with clinical, biological and endoscopic outcomes during maintenance therapy in inflammatory bowel disease

Frontline Gastroenterology
2020-03 | Journal article
DOI: 10.1136/flgastro-2019-101197
Contributors: Nikolas Plevris; Philip W Jenkinson; Cher S Chuah; Mathew Lyons; Lynne M Merchant; Rebecca J Pattenden; Ian D Arnott; Gareth R Jones; Charlie W Lees
Source: check_circle
Crossref

IBD prevalence in Lothian, Scotland, derived by capture–recapture methodology

Gut
2019-11-11 | Journal article
DOI: 10.1136/gutjnl-2019-318936
Contributors: Gareth-Rhys Jones; Mathew Lyons; Nikolas Plevris; Philip W Jenkinson; Cathy Bisset; Christopher Burgess; Shahida Din; James Fulforth; Paul Henderson; Gwo-Tzer Ho et al.
Source: check_circle
Crossref

Association Between Level of Fecal Calprotectin and Progression of Crohn's Disease

Clinical Gastroenterology and Hepatology
2019-10 | Journal article
DOI: 10.1016/j.cgh.2019.02.017
Contributors: Nicholas A. Kennedy; Gareth-Rhys Jones; Nikolas Plevris; Rebecca Patenden; Ian D. Arnott; Charlie W. Lees
Source: check_circle
Crossref

Higher anti-tumor necrosis factor levels are associated with perianal fistula healing and fistula closure in Crohn’s disease

European Journal of Gastroenterology & Hepatology
2019-09 | Journal article
DOI: 10.1097/meg.0000000000001561
Part of ISSN: 0954-691X
Source: Self-asserted source
Nikolas Plevris

Real-world Effectiveness and Safety of Vedolizumab for the Treatment of Inflammatory Bowel Disease: The Scottish Vedolizumab Cohort

Journal of Crohn's and Colitis
2019-09-19 | Journal article
DOI: 10.1093/ecco-jcc/jjz042
Contributors: N Plevris; C S Chuah; R M Allen; I D Arnott; P N Brennan; S Chaudhary; A M D Churchhouse; S Din; E Donoghue; D R Gaya et al.
Source: check_circle
Crossref

Implementation of CT-P13 via a Managed Switch Programme in Crohn’s Disease: 12-Month Real-World Outcomes

Digestive Diseases and Sciences
2019-06-15 | Journal article
DOI: 10.1007/s10620-018-5406-8
Contributors: Nikolas Plevris; Gareth R. Jones; Philip W. Jenkinson; Mathew Lyons; Cher S. Chuah; Lynne M. Merchant; Rebecca J. Pattenden; Eleanor F. Watson; Gwo-Tzer Ho; Colin L. Noble et al.
Source: check_circle
Crossref

Higher Adalimumab Drug Levels During Maintenance Therapy for Crohn’s Disease Are Associated With Biologic Remission

Inflammatory Bowel Diseases
2019-05-04 | Journal article
DOI: 10.1093/ibd/izy320
Contributors: Nikolas Plevris; Mathew Lyons; Philip W Jenkinson; Cher S Chuah; Lynne M Merchant; Rebecca J Pattenden; Eleanor F Watson; Gwo-Tzer Ho; Colin L Noble; Alan G Shand et al.
Source: check_circle
Crossref

Index serum hyaluronic acid independently and accurately predicts mortality in patients with liver disease

Alimentary Pharmacology & Therapeutics
2018-08 | Journal article
DOI: 10.1111/apt.14897
Contributors: N. Plevris; R. Sinha; A. W. Hay; N. McDonald; J. N. Plevris; P. C. Hayes
Source: check_circle
Crossref

Peer review (1 review for 1 publication/grant)

Review activity for Digestive diseases and sciences. (1)
How many people are using ORCID?